Key result
Study outlines infective endocarditis mortality trends linked to substance use without reporting quantitative outcomes.
Why the study?
The epidemiology of infective endocarditis has changed with an increase in younger patients and people who inject drugs, necessitating characterization of mortality trends in this population.
Observational
Answers are grounded in this paper and cite their sources.
Infective endocarditis (IE) affects 40,000 to 50,000 patients in the United States per year and has 1-year average mortality of 30% that has remained largely unchanged in the last two decades despite advances in diagnostic and therapeutic strategies [1]. Prosthetic cardiac devices, hemodialysis, intravenous catheters, immunosuppression and intravenous drug use constitute the main risk factors for IE [2]. A recent increase of IE in younger patients and people who inject drugs (PWID) has been noted since 2010, likely as a result of the ongoing opioid epidemic in the United States and particularly the increase in heroin abuse [3, 4]. Among PWID, IE deaths reportedly tripled between 1999 and 2016 [5]. Given the changing epidemiology of IE and the ongoing opioid epidemic in the United States, we sought to better characterize trends in mortality rates from IE among young US residents and in relation to drug abuse.
No takes yet. Share an insight, caveat, or question.
McLaughlin et al. (2022) conducted an observational in Infective endocarditis. Drug abuse (injection drug use) was evaluated. The provided abstract outlines an objective to characterize trends in infective endocarditis mortality among young US residents related to drug abuse, but reports no quantitative results.
Synapse has enriched 10 related papers. Consider them for comparative context: